Sudden cardiac death in COVID-19 patients, a report of three cases.
Samira ShiraziSanaz MamiNegar MohtadiAbas GhaysouriHamed TavanAli NazariTaleb KokhazadehReza MollazadehPublished in: Future cardiology (2020)
The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 patients were diagnosed based on reverse transcriptase-polymerase chain reaction of a nasopharyngeal swab test and radiological examinations in our hospital. The patients received medications at the discretion of the treating physician. In this case series, chest computed tomography scans and electrocardiograms, along with other diagnostic tests were used to evaluate these individuals. Sudden cardiac death in COVID-19 patients is not common, but it is a major concern. So, it is recommended to monitor cardiac condition in selected patients with COVID-19.
Keyphrases
- sars cov
- coronavirus disease
- computed tomography
- end stage renal disease
- respiratory syndrome coronavirus
- ejection fraction
- newly diagnosed
- healthcare
- emergency department
- primary care
- magnetic resonance imaging
- liver failure
- respiratory failure
- peritoneal dialysis
- heart failure
- cardiovascular events
- positron emission tomography
- cardiovascular disease
- drug induced
- acute care
- patient reported outcomes
- patient reported
- adverse drug
- community acquired pneumonia
- image quality